NCT06015113 2023-08-29Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain MetastasisXi'an International Medical Center HospitalPhase NA Not yet recruiting20 enrolled